Halozyme Therapeutics Shares Are Trading Higher After the Company Reported Preliminary Financial Results and Raised Its FY25 Guidance.
Halozyme Therapeutics Shares Are Trading Higher After the Company Reported Preliminary Financial Results and Raised Its FY25 Guidance.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.